1. Human immune repertoire in hepatitis B virus infection
    Qiao Zhan et al, 2021, World Journal of Gastroenterology CrossRef
  2. Intrahepatic TH17/TReg Cells in Homeostasis and Disease—It’s All About the Balance
    Hannah K. Drescher et al, 2020, Frontiers in Pharmacology CrossRef
  3. Recovery of host adaptive immune function promoted the reduction of hepatitis B surface antigen in nucleoside analog-experienced chronic hepatitis B patients with low hepatitis B surface antigen levels
    Qian Zhang et al, 2023, Cytokine CrossRef
  4. The Effects of Nucleoside/Nucleotide Analogues on Host Immune Cells: The Baseline for Future Immune Therapy for HBV?
    Lauke L Boeijen et al, 2020, Antiviral Therapy CrossRef
  5. Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma
    Wen-Jie Wang et al, 2020, Frontiers in Genetics CrossRef
  6. Characteristics of regulatory T‐cell function in patients with chronic hepatitis B and C coinfection
    Chih‐Wei Tseng et al, 2020, Journal of Viral Hepatitis CrossRef
  7. Low Ratio of Treg to Th17 Cells After 36 Weeks of Telbivudine Therapy Predict HBeAg Seroconversion
    Meng-Lan Wang et al, 2016, Viral Immunology CrossRef
  8. Immune Regulation by T Regulatory Cells in Hepatitis B Virus‐Related Inflammation and Cancer
    N. Trehanpati et al, 2017, Scandinavian Journal of Immunology CrossRef
  9. The frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4+CD25+ regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment
    Jiezuan Yang et al, 2016, Cellular & Molecular Immunology CrossRef
  10. Effect of WSP, a Chinese Herbal Formula, on Th17/Treg Ratio and HBeAg Seroconversion in Telbivudine-Treated HBeAg-Positive Chronic Hepatitis B Patients with High Baseline ALT Levels (20–30 Times the ULN)
    Yang Zhang et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
  11. Combination of pegylated interferon-alpha and nucleos(t)ide analogue treatment enhances the activity of natural killer cells in nucleos(t)ide analogue experienced chronic hepatitis B patients
    X Pang et al, 2020, Clinical and Experimental Immunology CrossRef